| Schedule of Common Stock |
Schedule
of Common Stock
| | |
| | |
| Schedule of Common Stock | |
| | |
| Issuance of Common Stock for compensation and as payment in lieu of cash payments for accrued liabilities | |
| 2,564,492 | |
| Exercise of options (Note 10) | |
| 48,718 | |
| Issuance of Common Stock converted for Convertible Note | |
| 105,440 | |
| | |
| | |
| Total | |
| 2,718,650 | |
|
Schedule
of Common Stock
| As of December 31, 2021 | |
| 2,512,815 | |
| Issuance of Common Stock for legal settlement | |
| 3,000 | |
| Exercise of options (Note 11) | |
| 3,006 | |
| Restricted stock award | |
| 8,224 | |
As of December 31, 2022
| |
| 2,527,045 | |
| Issuance of common stock | |
| 350,000 | |
| As of December 31, 2023 | |
| 2,877,045 | |
|
| Schedule of Common Stock Warrant |
Schedule of Common Stock Warrants
| | |
| | |
| | |
Weighted | | |
| |
| | |
| | |
Weighted | | |
Average | | |
| |
| | |
| | |
Average | | |
Remaining | | |
Aggregate | |
| | |
Number of | | |
Exercise | | |
Contractual | | |
Intrinsic | |
| | |
Shares | | |
Price | | |
Life (years) | | |
Value | |
| Outstanding at December 31, 2023 | |
| 24,415 | | |
| 0.11 | | |
| 1.82 | | |
| 1,200,387 | |
| Granted | |
| - | | |
| - | | |
| - | | |
| | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| | |
| Forfeited/cancelled | |
| - | | |
| - | | |
| - | | |
| | |
| Outstanding at June 30, 2024 | |
| 24,415 | | |
$ | 0.11 | | |
| 1.32 | | |
$ | 1,200,387 | |
|
Schedule
of Common Stock Warrant
| | |
| | |
| | |
Weighted | | |
| |
| | |
| | |
Weighted | | |
Average | | |
| |
| | |
| | |
Average | | |
Remaining | | |
Aggregate | |
| | |
Number of | | |
Exercise | | |
Contractual | | |
Intrinsic | |
| | |
Shares | | |
Price | | |
Life (years) | | |
Value | |
| Outstanding at December 31, 2021 | |
| 19,784 | | |
$ | 2.20 | | |
| 4.0 | | |
$ | 272,638 | |
| Granted | |
| 4,631 | | |
| 151.20 | | |
| 3.8 | | |
| 0 | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| | |
| Forfeited/cancelled | |
| - | | |
| - | | |
| - | | |
| | |
| Outstanding at December 31, 2022 | |
| 24,415 | | |
| 0.11 | | |
| 2.8 | | |
| 1,200,387 | |
| Granted | |
| - | | |
| - | | |
| - | | |
| | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| | |
| Forfeited/cancelled | |
| - | | |
| - | | |
| - | | |
| | |
| Outstanding at December 31, 2023 | |
| 24,415 | | |
$ | 0.11 | | |
| 1.8 | | |
$ | 1,200,387 | |
Beneficial
Conversion Feature - Convertible Debt
As
detailed in Note 10 - Notes Payable and Convertible Debt, the Company has issued two series of convertible debt. Both issuances
resulted in the recognition of the beneficial conversion features contained within both of the instruments. The Company recognized the
proceeds allocable to the beneficial conversion feature of $8,480,697
as additional paid in capital and a corresponding
debt discount of $2,795,000.
This additional paid in capital is reflected in the accompanying consolidated Statements of Equity.
Earnout
Shares
As
detailed in Note 4 - as part of the TDAC Combination as of December 31, 2021 a total of 5,000,000
Earnout Shares were eligible for issuance until December 31, 2022. Conditions for the earnout were not met and the potential earnout
shares were forfeited on December 31, 2022.
|